These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14165094)

  • 1. [A STUDY ON THE INHERITABLE FACTORS OF GOUT AND HYPERURICEMIA].
    ODA H
    Fukuoka Igaku Zasshi; 1964 Feb; 55():37-56. PubMed ID: 14165094
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES ON HYPERURICEMIA. II. A RECONSIDERATION OF THE DISTRIBUTION OF SERUM URIC ACID VALUES IN THE FAMILIES OF SMYTH, COTTERMAN, AND FREYBERG.
    NEEL JV; RAKIC MT; DAVIDSON RT; VALKENBURG HA; MIKKELSEN WM
    Am J Hum Genet; 1965 Jan; 17(1):14-22. PubMed ID: 14255552
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON CASES OF GOUT AND FAMILIAL HYPERURICEMIA].
    ICHISEKI H; ARAI K
    Nihon Seikeigeka Gakkai Zasshi; 1964 May; 38():149-58. PubMed ID: 14147962
    [No Abstract]   [Full Text] [Related]  

  • 4. OBSERVATIONS ON THE NATURAL HISTORY OF HYPERURICEMIA AND GOUT. I. AN EIGHTEEN YEAR FOLLOW-UP OF NINETEEN GOUTY FAMILIES.
    RAKIC MT; VALKENBURG HA; DAVIDSON RT; ENGELS JP; MIKKELSEN WM; NEEL JV; DUFF IF
    Am J Med; 1964 Dec; 37():862-71. PubMed ID: 14246088
    [No Abstract]   [Full Text] [Related]  

  • 5. ASSOCIATION OF HYPERURICEMIA AND POLYCYSTIC KIDNEY DISEASE.
    RIVERA JV; MARTINEZ MALDONADO M; RAMIREZDEARELLANO GA; EHRLICH L
    Bol Asoc Med P R; 1965 May; 57():251-62. PubMed ID: 14300767
    [No Abstract]   [Full Text] [Related]  

  • 6. ANKYLOSING SPONDYLITIS, HYPERURICEMIA, AND ANOMALIES OF THE LUMBOSACRAL JUNCTION. A FAMILY STUDY.
    THOMPSON GR; MARTEL W; RAKIC MT; HAYES JT
    Ann Intern Med; 1963 Dec; 59():849-58. PubMed ID: 14082736
    [No Abstract]   [Full Text] [Related]  

  • 7. Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S35-43. PubMed ID: 21654268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [THE ROLE OF THE NORMAL KIDNEY AND THE PATHOLOGICAL KIDNEY IN THE GENESIS OF HYPERURICEMIA].
    MUGLER A; BLOCH R; VOGT R
    Rein Foie; 1965; 7():175-88. PubMed ID: 14337640
    [No Abstract]   [Full Text] [Related]  

  • 9. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiology and dynamics of uric acid in hyperuricemia].
    Takagi K; Nakamura T; Ueda T
    Nihon Rinsho; 2008 Apr; 66(4):669-74. PubMed ID: 18409512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RENAL LESIONS RESULTING FROM INDUCED HYPERURICEMIA IN ANIMALS.
    DUNCAN H; WAKIM KG; WARD LE
    Proc Staff Meet Mayo Clin; 1963 Sep; 38():411-21. PubMed ID: 14064414
    [No Abstract]   [Full Text] [Related]  

  • 12. The genetics of gout and hyperuricaemia; an analysis of 19 families.
    SMYTH CJ; COTTERMAN CW; FREYBERG RH
    J Clin Invest; 1948 Nov; 27(6):749-59. PubMed ID: 18101596
    [No Abstract]   [Full Text] [Related]  

  • 13. Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S19-26. PubMed ID: 21654266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overproduction of uric acid as the cause of hyperuricemia in primary gout.
    WYNGAARDEN JB
    J Clin Invest; 1957 Oct; 36(10):1508-15. PubMed ID: 13475488
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic factors associated with gout and hyperuricemia.
    Bleyer AJ; Hart TC
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):124-30. PubMed ID: 16580613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S44-9. PubMed ID: 21654269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HYPERURICEMIA AND GOUT WITH DIURETICS].
    GAST LF
    Folia Med Neerl; 1965 Apr; 8():58-64. PubMed ID: 14327116
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of hyperuricemia in gout].
    CHABOT J; CANET L
    Sem Hop; 1953 Jul 4-10; 29(46-7):2394-8. PubMed ID: 13089773
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of hyperuricemia in gout; physiological principles].
    FREZAL J
    Sem Hop; 1953 Jul 4-10; 29(46-7):2390-4. PubMed ID: 13089772
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hyperuricemia in Filipinos].
    SISON AB; REYES MG; GUTIERREZ MT
    Minerva Med; 1961 Oct; 52():3694-6. PubMed ID: 13913478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.